OPI 409 (Chlordiazepoxide Hydrochloride and Clidinium Bromide 5 mg / 2.5 mg)

Pill with imprint OPI 409 is Green, Capsule-shape and has been identified as Chlordiazepoxide Hydrochloride and Clidinium Bromide 5 mg / 2.5 mg. It is supplied by Oceanside Pharmaceuticals, Inc..

Chlordiazepoxide/clidinium is used in the treatment of irritable bowel syndrome; enterocolitis; peptic ulcer and belongs to the drug class anticholinergics/antispasmodics. There is positive evidence of human fetal risk during pregnancy. Chlordiazepoxide/clidinium 5 mg / 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for OPI 409

Chlordiazepoxide Hydrochloride and Clidinium Bromide

Imprint:

OPI 409

Strength:

5 mg / 2.5 mg

Color:

Green

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Anticholinergics/antispasmodics

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Oceanside Pharmaceuticals, Inc.

Inactive Ingredients:

corn starch
lactose
magnesium silicate
methylparaben
propylparaben
potassium sorbate
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Green No. 3
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer